A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis |
Device: VANGUARD 360 |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee |
- AMERICAN KNEE SOCIETY KNEE SCORE [ Time Frame: 24 months postoperative ] [ Designated as safety issue: No ]Improvement of American Knee Society Knee Score between pre operative and 2 years post-operative follow up
- AMERICAN KNEE SOCIETY FUNCTION SCORE [ Time Frame: 24 months postoperative ] [ Designated as safety issue: No ]Improvement of American Knee Society Function Score between pre operative and 2 years post-operative follow up
- Device related complications [ Time Frame: 10 years postoperative ] [ Designated as safety issue: Yes ]Survivorship at 10 years post-operative follow up
- Radiographic evaluation [ Time Frame: 5 years postoperative ] [ Designated as safety issue: Yes ]Radiographic evaluation at 6 months, 1year, 2 years, 3 years and 5 years post-operative visit
| Estimated Enrollment: | 255 |
| Study Start Date: | March 2012 |
| Estimated Study Completion Date: | April 2024 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Vanguard 360
Vanguard SSK360 with PS Bearing: 85 total cases Vanguard SSK360 with PSC Bearing: 85 total cases Vanguard DA360: 85 total cases
|
Device: VANGUARD 360
VANGUARD 360 REVISION KNEE SYSTEM
Other Name: VANGUARD 360 REVISION KNEE SYSTEM
|
Detailed Description:
This investigation is being conducted on a new complete revision knee system, Vanguard 360, which incorporates:
- Fixed Bearing Knee - Vanguard SSK360 with PS Bearing and PSC Bearing
- Mobile Bearing Knee - Vanguard DA360
- Hinged Knee - Vanguard BCH 360 (will not be investigated until this design is CE Marked) The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.
The efficacy and safety of the devices will be assessed by improvement of pain, function, range of motion and patient satisfaction measured from pre-operatively to post-operatively. Secondary performance and safety will be determined by radiographic investigation, incidence of complications and revision rates.
The data gathered would be collated and used to provide feedback to designing engineers; support marketing efforts, and answer potential questions from reimbursement agencies.
Surgical techniques and patient care are to be standard for the surgeon participating in the protocol. There will be no experimental or investigational devices used. There will be no experimental or investigational surgical techniques used. The devices and products will be used in accordance with their instructions for use and/or approved labeling.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
- Correction of varus, valgus or post-traumatic deformity
- Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure
- Ability and willingness of the patient to attend follow-up visit.
- Willing to give written informed consent
- Patients are at least 18 years of age, no upper age limit, must have reached full skeletal maturity.
Exclusion Criteria:
- Acute infection at the time of surgery, sepsis, and osteomyelitis
- An uncooperative patient or a patient with neurologic disorders who is incapable of following directions
- Metabolic disorders which may impair bone formation
- Osteomalacia
- Distant source(s) of infections which may spread to the implant site
- Vascular insufficiency, muscular atrophy, neuromuscular disease
Contacts and Locations| Contact: Maggie SHEN | 01793607601 ext +44 | maggie.shen@biomet.com |
| Belgium | |
| University Hopital Pellenberg | Recruiting |
| Pellenberg, Belgium | |
| Contact: Bellemans, Pr | |
| Principal Investigator: Bellemans, Pr | |
| Denmark | |
| Aarhus university hospital | Recruiting |
| Aarhus, Denmark | |
| Contact: A Odgaard, Dr | |
| Principal Investigator: A Odgaard, Dr | |
| France | |
| Ch Lyon Sud | Recruiting |
| Lyon, France, 69000 | |
| Contact: Julien Chouteau, Dr | |
| Principal Investigator: Julien CHOUTEAU, Dr | |
| Germany | |
| Klinik fur Endoprothetik und gelenkchirurgie | Recruiting |
| Bad Wildbad, Germany | |
| Contact: Stefan SELL, Pr | |
| Principal Investigator: Stefan SELL, Pr | |
| Italy | |
| Casa di Cura Abano Terme | Withdrawn |
| Abano Terme, Padova, Italy | |
| Spain | |
| University Hospital Mutua de Tarrasa | Recruiting |
| Tarrasa, Spain | |
| Contact: S Sabates, Dr | |
| Principal Investigator: S SABATES, Dr | |
| United Kingdom | |
| University Hospital of Wales | Not yet recruiting |
| Cardiff, Wales, United Kingdom | |
| Contact: R Morgan-Jones | |
| Principal Investigator: R Morgan-Jones | |
| Sub-Investigator: M Forster | |
| Royal Orthopaedic Hospital | Recruiting |
| Birmingham, United Kingdom, B31 2AP | |
| Contact: Simon CARTER, Mr | |
| Principal Investigator: Simon CARTER, Mr | |
| Sub-Investigator: Lee JEYS, Mr | |
| Principal Investigator: | Simon CARTER, Mr | ROYAL ORTHOPAEDIC HOSPITAL |
More Information
No publications provided
| Responsible Party: | Biomet, Inc. |
| ClinicalTrials.gov Identifier: | NCT01542580 History of Changes |
| Other Study ID Numbers: | BMETEU.CR.G1 |
| Study First Received: | February 27, 2012 |
| Last Updated: | May 14, 2013 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Biomet, Inc.:
|
Revision surgery |
Additional relevant MeSH terms:
|
Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |
ClinicalTrials.gov processed this record on May 22, 2013